Clarivate (NYSE:CLVT) Trading 7.3% Higher – Should You Buy?

Posted by Geri Gentry on Jul 30th, 2026

Shares of Clarivate PLC (NYSE:CLVT – Get Free Report) shot up 7.3% during mid-day trading on Tuesday . The company traded as high as $2.25 and last traded at $2.2850. Approximately 526,768 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 6,739,806 shares. The stock had previously closed at $2.13.

Trending Headlines about Clarivate

Here are the key news stories impacting Clarivate this week:

Positive Sentiment: Clarivate reported adjusted earnings of $0.19 per share, ahead of analyst estimates of approximately $0.17-$0.18 and up from $0.18 a year earlier. Clarivate PLC Q2 Earnings and Revenues Beat Estimates
Positive Sentiment: Management reaffirmed its 2026 financial outlook and said its Value Creation Plan is improving execution, sharpening the company’s strategic focus and supporting efforts to accelerate organic growth. Clarivate is also advancing the previously announced divestiture of its Life Sciences & Healthcare segment to improve its financial profile. Clarivate Reports Second Quarter 2026 Results
Positive Sentiment: The earnings call highlighted strategic shifts and expanded use of artificial intelligence, which could support product innovation and longer-term competitiveness if these initiatives translate into stronger growth. Clarivate Q2 2026 Earnings Call Highlights
Neutral Sentiment: Clarivate appointed longtime company executive Michael Easton as executive vice president and CFO, effective August 8. He succeeds Jonathan Collins, who is leaving to pursue another opportunity. Easton brings more than 25 years of financial and operational experience, providing continuity but adding a management transition. Clarivate Appoints Michael Easton as Chief Financial Officer
Negative Sentiment: Quarterly revenue of $587.3 million fell 5.5% year over year and was slightly below the roughly $589.7 million consensus estimate. Clarivate also continues to report a negative net margin, underscoring pressure on profitability despite the adjusted EPS beat. Clarivate Quarterly Earnings Report

Wall Street Analyst Weigh In

Several equities analysts recently commented on CLVT shares. Barclays reduced their price target on Clarivate from $2.50 to $2.00 and set an “underweight” rating on the stock in a research report on Thursday. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a research report on Wednesday, June 24th. Finally, Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Four investment analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and a consensus price target of $2.88.

Check Out Our Latest Report on Clarivate

Clarivate Trading Down 10.6%

The business’s 50-day simple moving average is $2.29 and its two-hundred day simple moving average is $2.43. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89. The company has a market capitalization of $1.37 billion, a PE ratio of -10.21 and a beta of 1.38.

Clarivate (NYSE:CLVT – Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.01. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The business had revenue of $587.30 million for the quarter, compared to analyst estimates of $589.73 million. During the same period in the previous year, the company earned $0.18 earnings per share. The company’s revenue for the quarter was down 5.5% compared to the same quarter last year. On average, analysts predict that Clarivate PLC will post 0.65 earnings per share for the current year.

Institutional Investors Weigh In On Clarivate

Hedge funds and other institutional investors have recently bought and sold shares of the business. Personal CFO Solutions LLC purchased a new position in shares of Clarivate during the 1st quarter valued at approximately $30,000. FreeGulliver LLC bought a new position in Clarivate during the 1st quarter valued at $30,000. Principal Financial Group Inc. acquired a new position in Clarivate during the 1st quarter worth $32,000. M&T Bank Corp bought a new stake in shares of Clarivate in the 4th quarter worth about $34,000. Finally, Parallel Advisors LLC lifted its position in shares of Clarivate by 94.2% during the first quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock worth $35,000 after purchasing an additional 6,687 shares during the last quarter. 85.72% of the stock is currently owned by hedge funds and other institutional investors.

Clarivate Company Profile

(Get Free Report)

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.